Anticholinesterase (DFP) toxicity antagonism by chronic donepezil: A potential nerve agent treatment

Pharmacology Biochemistry and Behavior

Volumn 81, Issue 4, 2005, Pages 917-922

  Janowsky, David S ^a   Davis, John M ^b   Overstreet, David H ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

Acetylcholine; Cholinesterase inhibitors; Diarrhea; Diisopropylfluorophosphate (DFP); Donepezil; Hypothermia; Sarin; Soman

Indexed keywords

CHOLINESTERASE; CHOLINESTERASE INHIBITOR; DONEPEZIL; DYFLOS;

ACUTE DRUG ADMINISTRATION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; DIARRHEA; DRUG EFFECT; HYPOKINESIA; HYPOTHERMIA; INJECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTECTION; RAT; RAT STRAIN; TIME; TOXICITY;

ANIMALS; BEHAVIOR, ANIMAL; BODY TEMPERATURE; CHOLINESTERASE INHIBITORS; DIARRHEA; HYPOKINESIA; INDANS; INJECTIONS, INTRAMUSCULAR; INJECTIONS, INTRAPERITONEAL; ISOFLUROPHATE; MALE; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

ANIMALIA;

EID: 23944483139     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pbb.2005.06.017     Document Type: Article

References (41)

1. D.R. Anderson, L.W. Harris, W.J. Lennox, and R.P. Solana Effects of subacute pretreatment with carbamate together with adjunct pretreatment against nerve agent exposure Drug Chem Toxicol 14 1-2 1991 1 19
2. D.R. Anderson, C. Gennings, W.H. Carter, L.W. Harris, W.J. Lennox, and S.L. Bowersox Efficacy comparison of scopolamine and diazepam against soman-induced debilitation in guinea pigs Fundam Appl Toxicol 22 4 1994 588 593
3. T.C. Chippendale, G.A. Zawolkow, R.W. Russell, and D.H. Overstreet Tolerance to low acetylcholinesterase levels: Modification of behavior without acute behavioral change Psychopharmacologia 26 1972 l27 l39
4. A. Clegg, J. Bryant, T. Nicholson, L. McIntyre, S. De Broe, and K. Gerard Clinical and cost-effectiveness of donepezil, rivastigmine and galantamine for Alzheimer's disease. A systematic review Int J Technol Assess Health Care 18 2002 497 507
5. F. Coelho, and J. Birks Physostigmine for Alzheimer's disease Cochrane Database Syst Rev 2 2001 CD001499
6. S.S. Deshponde, G.G. Viana, F.C. Kauffman, D.L. Rickett, and E.X. Albuquerque Effectiveness of physostigmine as a pretreatment drug for protection of rats from organophosphate poisoning Fundam Appl Toxicol 6 1986 566 577
7. P. Dirnhuber, M.C. French, D.M. Green, L. Leadbeater, and J.A. Stratton The protection of primates against soman poisoning by pretreatment with pyridostigmine J Pharm Pharmacol 31 1979 295 299
8. M.C. French, Wetherell Jr., and P.D. White The reversal by pyridostigmine of neuromuscular block produced by soman J Pharm Pharmacol 31 1979 290 294
9. H. Geerts, P.O. Guillaumat, C. Grantham, W. Bode, K. Anciaux, and S. Sachak Brain levels and acetylcholinesterase inhibition with galantamine and donepezil in rats, mice, and rabbits Brain Res 1033 2005 186 193
10. L.W. Harris, B.G. Talbot, W.J. Lennox, D.R. Anderson, and R.P. Solana Physostigmine (alone and together with adjunct) pretreatment against soman, sarin, tabun and VX intoxication Drug Chem Toxicol 14 1991 265 281
11. D.F. Heath Organophosphorus poisons 1961 Pergamon Press New York
12. F. Inglis The tolerability and safety of cholinesterase inhibitors in the treatment of dementia Int J Clin Pract 127S 2002 45 63
13. D.S. Janowsky Central anticholinergics to treat nerve agent poisoning Lancet 359 9302 2002 265 266
14. D.S. Janowsky, A. Berkowitz, A. Turken, and S.C. Risch Antagonism of physostigmine induced lethality by a combination of scopolamine and methscopolamine Acta Pharm Toxicol 56 1985 154 157
15. D.S. Janowsky, D.S. Risch, A. Berkowitz, A. Turken, and M. Drennan Central versus peripheral antagonism of cholinesterase inhibitor induced lethality I. Hanin Dynamics of Cholinergic Function 1986 Lenum Publishing Corp 791 798
16. D. Janowsky, S.C. Risch, M. Ziegler, and J.C. Gillin Antagonistic effects of scopolamine and atropine on the physostigmine response in man Mil Med 152 1987 579 581
17. D.S. Janowsky, D.H. Overstreet, and J.I. Nurnberger Jr. Is cholinergic sensitivity a genetic marker for affective disorder? Am J Med Genet 1994 335 344
18. D.S. Janowsky, J.M. Davis, and D.H. Overstreet Antagonism of anticholinesterase (DFP) toxicity by donepezil plus scopolamine: a preliminary study Pharmacol Biochem Behav 77 2004 337 343
19. V. Kaasinen, K. Nagren, T. Jarvenpaa, A. Roivainen, M. Yu, and T. Oikonen Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease J Clin Psychopharmacol 22 2002 615 620
20. J.F. Keeler, G.G. Hurst, and N. Dunn Pyridostigmine used as a nerve agent pretreatment under wartime conditions JAMA 266 1991 693 695
21. G. Lallement, A. Foquin, F. Dorandeu, D. Baubichon, and P. Carpentier Subchronic administration of various pretreatments of nerve gas poisoning. II. Compared efficacy against soman toxicity Drug Chem Toxicol 24 2001 165 180
22. L. Leadbeater, R.H. Inns, and J.M. Rylands Treatment of poisoning by soman Fundam Appl Toxicol 5 1985 S225 S231
23. D.K. Lim, Y. Ito, H.J. Yu, B. Hoskins, and I.K. Ho Prevention of soman toxicity after the continuous administration of physostigmine Pharmacol Biochem Behav 31 3 1988 633 639
24. D.K. Lim, B. Hoskins, and I.K. Ho Trihexyphenidyl enhances physostigmine prophylaxis against poisoning in guinea pigs Fundam Appl Toxicol 16 1991 482 489
25. Y. Meshulam, R. Davidovici, A. Wengier, and A. Levy Prophylactic transdermal treatment with physostigmine and scopolamine against soman intoxication in guinea-pigs J Appl Toxicol 15 1995 263 266
26. S.A. Miller, D.W. Blick, S.Z. Kerenyi, and M.R. Murphy Efficacy of physostigmine as a pretreatment for organophosphate poisoning Pharmacol Biochem Behav 44 2 1993 343 347
27. J.C. Morris, P.A. Cyrus, J. Orazem, J. Mas, F. Bieber, and B.B. Rusicka Metrifonate benefits cognitive, behavioral, and global function in patients with Alzheimer's disease Neurology 50 1998 1222 1230
28. D.H. Overstreet Reduced behavioral effects of pilocarpine during chronic treatment with DFP Behav Biol l1 1974 49 58
29. D.H. Overstreet, Y. Yang, and A.H. Rezvani Failure of pyridostigmine pretreatment to protect against the effects of chlorpyrifos Presented at Conference on Federally Sponsored Gulf War Veterans' Illnesses Research, Pentagon City, VA, June 17-19 1998
30. D.H. Overstreet, Y. Yang, E. Clark, and A.H. Rezvani More rapid decreases in temperature following anticholinesterase challenges in rats pretreated with pyridostigmine Presented at 16th International Conference on Neurotoxicology, Little Rock, AR September 14 1998
31. I.H. Philippens, B.P. Melchers, B. Olivier, and P.L. Bruijnzeel Scopolamine augments the efficacy of physostigmine against soman poisoning in guinea pigs Pharmacol Biochem Behav 65 2000 175 182
32. R.D. Pratt, C.A. Perdomo, I.W. Surick, and J.R. Ieni Donepezil: tolerability and safety in Alzheimer's disease Int J Clin Pract 56 2002 710 717
33. G.C. Roman, and S.J. Rogers Donepezil: a clinical review of current and emerging indications Expert Opin Pharmacother 5 2004 161 180
34. M. Rosler The efficacy of cholinesterase inhibitors in treating the behavioral symptoms of dementia Int J Clin Pract 127S 2002 20 36
35. R.P. Solana, D. Gennings, W.H.J. Carter, D. Anderson, W.J. Lennox, R.A. Carchman, and L.W. Harris Evaluation of the efficacy of two carbamates, physostigmine and pyridostigmine, when used in conjunction for protection against organophosphate exposure Fundam Appl Toxicol 15 1990 814 819
36. P. Taylor Anticholinesterase agents J.G. Hardman L.E. Limbird P.B. Molinoff R.W. Luddon A.G. Gilman The pharmacological basis of therapeutics 1996 McGraw-Hill New York 131 149
37. A.P. Volans Sarin: guidelines on the management of victims of a nerve gas attack J Accid Emerg Med 13 1996 202 206
38. J. von Bredow, K. Corcoran, G. Maitland, A. Kaminskis, N. Adams, and J. Wade Efficacy evaluation of physostigmine and anticholinergic adjuncts as a pretreatment for nerve agent intoxication Fundam Appl Toxicol 17 1991 782 789
39. P. Walday, P. Aas, T. Haider, and F. Fonnum Effect of pyridostigmine pretreatment, HI-6 and Toxogonin treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure Arch Toxicol 67 1993 212 219
40. C. Wolfson, M. Oremus, V. Shukla, F. Momoli, L. Demers, and A. Perrault Donepezil and rivastigmine in the treatment of Alzheimer's disease: a best-evidence synthesis of the published data on the efficacy and cost-effectiveness Clin Ther 24 2002 862 886
41. D.Y. Xia, L.X. Wang, and S.Q. Pei The inhibition and protection of cholinesterase by physostigmine and pyridostigmine against Soman poisoning in vivo Fundam Appl Toxicol 1 1981 217 221